Your Article Summary
A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized single-blind study.
BMC Psychiatry, 06/01/09
Prosser JM et al. - This study can identify no difference in the efficacy of paroxetine and low-dose risperidone in the treatment of panic attacks. Low-dose risperidone appears to be tolerated equally well as paroxetine. Low-dose risperidone may be an effective treatment for anxiety disorders in which panic attacks are a significant component.
Methods- Fifty six subjects with a history of panic attacks were randomized to receive either risperidone or paroxetine.
- The subjects were then followed for eight weeks.
- Outcome measures included the Panic Disorder Severity Scale (PDSS), the Hamilton Anxiety Scale (Ham-A), the Hamilton Depression Rating Scale (Ham-D), the Sheehan Panic Anxiety Scale-Patient (SPAS-P), and the Clinical Global Impression scale (CGI).
- All subjects demonstrated a reduction in both the frequency and severity of panic attacks regardless of treatment received.
- Statistically significant improvements in rating scale scores for both groups were identified for the PDSS, the Ham-A, the Ham-D, and the CGI.
- There was no difference between treatment groups in the improvement in scores on the measures PDSS, Ham-A, Ham-D, and CGI.
- Post hoc tests suggest that subjects receiving risperidone may have a quicker clinical response than subjects receiving paroxetine.
Related Articles
Dont panic about statin side-effects
Internet Source, 11/11/09
Relevance Score: 64%
Update on Marijuana
Journal of Psychosocial Nursing and Mental Health Services, 10/26/09
Relevance Score: 64%
Identifying target groups for the prevention of anxiety disorders in the general population
Acta Psychiatrica Scandinavica, 10/15/09
Relevance Score: 64%
Anxiety and mood disorders in narcolepsy: a case-control study
General Hospital Psychiatry, 10/07/09
Relevance Score: 64%
The heart attack myth: Study establishes that women do have same the heart attack symptoms as men
EurekAlert, 10/26/09
Relevance Score: 45%
Today in Anxiety...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel approaches to treatment of generalized anxiety disorder
Current Opinion in Psychiatry, 12/04/09
Depressive symptoms in persons with acute coronary syndrome: Specific symptom scales and prognosis
Journal of Psychosomatic Research, 12/04/09
Measures of stress in epidemiological research
Journal of Psychosomatic Research, 12/04/09
Today in Mood Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Preventing depression in high-risk groups
Current Opinion in Psychiatry, 12/04/09
Is poor premorbid functioning a risk factor for suicide attempts in first-admission psychosis
Schizophrenia Research, 12/04/09
Electrophysiological brain activity and antisaccade performance in schizophrenia patients with first-rank (passivity) symptoms
Psychiatry Research, 12/04/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Quetiapine treatment and improved cognitive functioning in borderline personality disorder
Human Psychopharmacology: Clinical and Experimental, 12/04/09
Mania associated with antidepressant treatment: comprehensive meta-analytic review
Acta Psychiatrica Scandinavica, 12/04/09
Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: An open-label study
World Journal of Biological Psychiatry, 12/03/09

See Latest Articles